A dual tracer 18F-FCH/18F-FDG PET imaging of an orthotopic brain tumor xenograft model

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Fu, Yilong ^a   Ong, Lai Chun ^a   Ranganath, Sudhir H ^a,e   Zheng, Lin ^b   Kee, Irene ^b   Zhan, Wenbo ^a   Yu, Sidney ^c   Chow, Pierce K H ^c,d   Wang, Chi Hwa ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e SIDDAGANGA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROCHOLINE F 18; FLUORODEOXYGLUCOSE F 18; TRACER; UNCLASSIFIED DRUG; CHOLINE; FLUOROCHOLINE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; FALSE POSITIVE RESULT; GLIOMA; HISTOLOGY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY ANALYSIS; TUMOR VOLUME; TUMOR XENOGRAFT; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN TUMOR; DIAGNOSTIC IMAGING; DISEASE MODEL; GLIOBLASTOMA; IMAGE PROCESSING; LUMINESCENCE; PROCEDURES; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHOLINE; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; GLIOBLASTOMA; HETEROGRAFTS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUMINESCENT MEASUREMENTS; MICE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84959018545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148123     Document Type: Article

References (31)

1. Wong TZ, van der Westhuizen GJ, Coleman RE. Positron emission tomography imaging of brain tumors. Neuroimaging clinics of North America. 2002; 12(4):615-26. PMID: 12687915
2. Engel H, Steinert H, Buck A, Berthold T, Huch BR, von Schulthess GK. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. Journal of nuclear medicine: official publication, Society of Nuclear Medicine. 1996; 37(3):441-6.
3. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. European journal of nuclear medicine. 1996; 23(10):1409-15. PMID: 8781149
4. Vallabhajosula S, editor 18 F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Seminars in nuclear medicine; 2007: Elsevier.
5. Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan C-N, Wolf AP. Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. Journal of Nuclear Medicine. 1978; 19(10):1154-61. PMID: 214528
6. DeGrado TR, Baldwin SW, Wang S, Orr MD, Liao RP, Friedman HS, et al. Synthesis and evaluation of 18F-labeled choline analogs as oncologic PET tracers. Journal of Nuclear Medicine. 2001; 42 (12):1805-14. PMID: 11752077
7. Hernandez-Alcoceba R, Saniger L, Campos J, Núñez MC, Khaless F, Gallo MA, et al. Choline kinase inhibitors as a novel approach for antiproliferative drug design. Oncogene. 1997; 15(19):2289-301. PMID: 9393874
8. HAEFFNER EW. Studies on Choline Permeation through the Plasma Membrane and Its Incorporation into Phosphatidyl Choline of Ehrlich-Lettré-Ascites Tumor Cells in vitro. European Journal of Biochemistry. 1975; 51(1):219-28. PMID: 1168133
9. Tosi R, Tugnoli V. Nuclear magnetic resonance spectroscopy in the study of neoplastic tissue: Nova Publishers; 2005.
10. Wyss MT, Spaeth N, Biollaz G, Pahnke J, Alessi P, Trachsel E, et al. Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP (L19), a marker of angiogenesis. Journal of Nuclear Medicine. 2007; 48(4):608-14. PMID: 17401099
11. Lam WW-C, Ng DC-E, Wong WY, Ong SC, Yu SW-K, See SJ. Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors - Early experience. Clinical neurology and neurosurgery. 2011; 113(2):156-61. doi: 10.1016/j.clineuro.2010.09.012 PMID: 21036467
12. Gómez-Río M, Dardel NT, Chinchilla AS, Rodríguez-Fernández A, Granados GO, Caro RL, et al. 18FFluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility. European journal of nuclear medicine and molecular imaging. 2015; 42(6):886-95. doi: 10.1007/s00259-015-2997-6 PMID: 25673054
13. Chen W. Clinical applications of PET in brain tumors. Journal of nuclear medicine. 2007; 48(9):1468-81. PMID: 17704239
14. Schaller B. Usefulness of positron emission tomography in diagnosis and treatment follow-up of brain tumors. Neurobiology of disease. 2004; 15(3):437-48. PMID: 15056451
15. Douglas JG, Stelzer KJ, Mankoff DA, Tralins KS, Krohn KA, Muzi M, et al. [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure. International Journal of Radiation Oncology, Biology, Physics. 2006; 64(3):886-91.
16. Tralins KS, Douglas JG, Stelzer KJ, Mankoff DA, Silbergeld DL, Rostomilly R, et al. Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation. Journal of Nuclear Medicine. 2002; 43(12):1667-73. PMID: 12468518
17. Blasberg R. Prediction of brain tumor therapy response by PET. Journal of neuro-oncology. 1994; 22 (3):281-6. PMID: 7760108
18. Kwee SA, Ko JP, Jiang CS, Watters MR, Coel MN. Solitary Brain Lesions Enhancing at MR Imaging: Evaluation with Fluorine 18-Fluorocholine PET 1. Radiology. 2007; 244(2):557-65. PMID: 17581887
19. Delbeke D. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer lymphoma and melanoma. The Journal of Nuclear Medicine. 1999; 40(4):591. PMID: 10210218
20. Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer research. 1995; 16(3B):1375-80.
21. Yoshimoto M, Waki A, Obata A, Furukawa T, Yonekura Y, Fujibayashi Y. Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate. Nuclear medicine and biology. 2004; 31 (7):859-65. PMID: 15464387
22. Shinoura N, Nishijima M, Hara T, Haisa T, Yamamoto H, Fujii K, et al. Brain tumors: detection with C-11 choline PET. Radiology. 1997; 202(2):497-503. PMID: 9015080
23. Hara T, Kosaka N, Shinoura N, Kondo T. PET imaging of brain tumor with (methyl-11C) choline. The Journal of Nuclear Medicine. 1997; 38(6):842. PMID: 9189127
24. Utriainen M, Komu M, Vuorinen V, Lehikoinen P, Sonninen P, Kurki T, et al. Evaluation of brain tumor metabolism with [11C] choline PET and 1H-MRS. Journal of neuro-oncology. 2003; 62(3):329-38. PMID: 12777086
25. Hara T. 18F-fluorocholine: a new oncologic PET tracer. Journal of Nuclear Medicine. 2001; 42 (12):1815-7. PMID: 11752078
26. Cook G. Oncological molecular imaging: nuclear medicine techniques. The British journal of radiology. 2014.
27. Weber WA, Wester H-J, Grosu AL, Herz M, Dzewas B, Feldmann H-J, et al. O-(2-[18F] fluoroethyl)-Ltyrosine and L-[methyl-11C] methionine uptake in brain tumours: initial results of a comparative study. European journal of nuclear medicine. 2000; 27(5):542-9. PMID: 10853810
28. Bradbury MS, Hambardzumyan D, Zanzonico PB, Schwartz J, Cai S, Burnazi EM, et al. Dynamic small-animal PET imaging of tumor proliferation with 30-deoxy-30-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas. Journal of Nuclear Medicine. 2008; 49(3):422-9. doi: 10.2967/jnumed.107.047092 PMID: 18287265
29. Casara D, Rubello D, Pelizzo M, Shapiro B. Clinical role of 99m TcO 4/MIBI scan, ultrasound and intraoperative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. European Journal of Nuclear Medicine and Molecular Imaging. 2001; 28 (9):1351-9.
30. Rubello D, Pelizzo M, Casara D. Nuclear medicine and minimally invasive surgery of parathyroid adenomas: a fair marriage. European journal of nuclear medicine and molecular imaging. 2003; 30(2):189-92. PMID: 12643287
31. Joshi A, Fessler J, Koeppe R, editors. Signal separation in dual-tracer brain PET imaging using reference region models. Society of Nuclear Medicine Annual Meeting Abstracts; 2007: Soc Nuclear Med.